Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04921_nanopub.RAJhsXEziSHqSxGemRs0zKQkDHCEIoFcFplHSjw-Mk2d8#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04921 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04921 label "MBP8298 [drugbank:DB04921]" assertion.
- drugbank:DB04921 seeAlso DB04921 assertion.
- drugbank:DB04921 description "MBP8298 is a synthetic peptide that consists of 17 amino acids linked in a sequence identical to that of a portion of human myelin basic protein (MBP). MBP8298 has been developed for the treatment of multiple sclerosis (MS). Developed at the University of Alberta, MBP8298 is being investigated by BioMS Medical Corp." assertion.
- drugbank:DB04921 identifier "drugbank:DB04921" assertion.
- drugbank:DB04921 title "MBP8298" assertion.
- drugbank:DB04921 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04921 drugbank_vocabulary:drugbank-id "DB04921" assertion.
- drugbank:DB04921 bio2rdf_vocabulary:x-identifiers.org DB04921 assertion.
- drugbank:DB04921 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04921" assertion.
- drugbank:DB04921 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04921 bio2rdf_vocabulary:identifier "DB04921" assertion.